The Composition of Hyperacute Serum and Platelet-Rich Plasma Is Markedly Different despite the Similar Production Method

Autologous blood derived products, such as platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) are widely applied in regenerative therapies, in contrast to the drawbacks in their application, mainly deriving from the preparation methods used. Eliminating the disadvantages of both PRP and PRF, hyperacute serum (HAS) opens a new path in autologous serum therapy showing similar or even improved regenerative potential at the same time. Despite the frequent experimental and clinical use of PRP and HAS, their protein composition has not been examined thoroughly yet. Thus, we investigated and compared the composition of HAS, serum, PRP and plasma products using citrate and EDTA by simple laboratory tests, and we compared the composition of HAS, serum, EDTA PRP and plasma by Proteome Profiler and ELISA assays. According to our results the natural ionic balance was upset in both EDTA and citrate PRP as well as in plasma. EDTA PRP contained significantly higher level of growth factors and cytokines, especially platelet derived angiogenic and inflammatory proteins, that can be explained by the significantly higher number of platelets in EDTA PRP. The composition analysis of blood derivatives revealed that although the preparation method of PRP and HAS were similar, the ionic and protein composition of HAS could be advantageous for cell function.

[1]  M. Neubauer,et al.  The Effect of Blood-Derived Products on the Chondrogenic and Osteogenic Differentiation Potential of Adipose-Derived Mesenchymal Stem Cells Originated from Three Different Locations , 2019, Stem cells international.

[2]  S. D'Ascenzo,et al.  In vitro evidence supporting applications of platelet derivatives in regenerative medicine. , 2019, Blood transfusion = Trasfusione del sangue.

[3]  N. Maffulli,et al.  Blood-Derived Products for Tissue Repair/Regeneration , 2019, International journal of molecular sciences.

[4]  A. Vlahou,et al.  Short Term Results of Fibrin Gel Obtained from Cord Blood Units: A Preliminary in Vitro Study , 2019, Bioengineering.

[5]  S. Szathmary,et al.  Investigation of Cytokine Changes in Osteoarthritic Knee Joint Tissues in Response to Hyperacute Serum Treatment , 2019, Cells.

[6]  Rucha J. Shah,et al.  Biological activation of bone grafts using injectable platelet-rich fibrin. , 2019, The Journal of prosthetic dentistry.

[7]  Shawn Shih.  Platelet‐rich plasma: Potential role in combined therapy for vitiligo , 2018, Dermatologic therapy.

[8]  W. Maloney,et al.  Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations From the 2018 AAOS/NIH U-13 Conference , 2018, The Journal of the American Academy of Orthopaedic Surgeons.

[9]  M. Satish,et al.  Autologous platelet-rich fibrin: can it secure a better healing? , 2019, Oral surgery, oral medicine, oral pathology and oral radiology.

[10]  S. Nehrer,et al.  Biological and Mechanical Properties of Platelet-Rich Fibrin Membranes after Thermal Manipulation and Preparation in a Single-Syringe Closed System , 2018, International journal of molecular sciences.

[11]  J. Dragoo,et al.  Current Clinical Recommendations for Use of Platelet-Rich Plasma , 2018, Current Reviews in Musculoskeletal Medicine.

[12]  L. Wang,et al.  [Clinical application of platelet-rich fibrin in chronic wounds combined with subcutaneous stalking sinus]. , 2018, Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns.

[13]  N. Maffulli,et al.  A contemporary view of platelet-rich plasma therapies: moving toward refined clinical protocols and precise indications. , 2018, Regenerative medicine.

[14]  S. Dolati,et al.  Platelet rich plasma, stromal vascular fraction and autologous conditioned serum in treatment of knee osteoarthritis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  J. Souza,et al.  Injectable platelet rich fibrin: cell content, morphological, and protein characterization , 2018, Clinical Oral Investigations.

[16]  W. Han,et al.  Hyperacute serum has markedly better regenerative efficacy than platelet-rich plasma in a human bone oxygen-glucose deprivation model. , 2018, Regenerative medicine.

[17]  Bennoune Omar,et al.  The effectiveness of platelet-rich plasma on the skin wound healing process: A comparative experimental study in sheep , 2018, Veterinary world.

[18]  S. Nehrer,et al.  The Effects of Hyperacute Serum on the Elements of the Human Subchondral Bone Marrow Niche , 2018, Stem cells international.

[19]  Nicola Maffulli,et al.  Advances with platelet rich plasma therapies for tendon regeneration , 2018, Expert Opinion on Biological Therapy.

[20]  M. Conconi,et al.  Leucocyte and Platelet‐rich Fibrin: a carrier of autologous multipotent cells for regenerative medicine , 2018, Journal of cellular and molecular medicine.

[21]  S. Nehrer,et al.  The Effects of Hyperacute Serum on Adipogenesis and Cell Proliferation of Mesenchymal Stromal Cells. , 2017, Tissue engineering. Part A.

[22]  S. Nehrer,et al.  Platelet-Rich Plasma Supports Proliferation and Redifferentiation of Chondrocytes during In Vitro Expansion , 2017, Front. Bioeng. Biotechnol..

[23]  F. Leonardi,et al.  The Contribution of Adipose Tissue-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma to the Treatment of Chronic Equine Laminitis: A Proof of Concept , 2017, International journal of molecular sciences.

[24]  J. U. Carmona,et al.  Long‐term cytokine and growth factor release from equine platelet‐rich fibrin clots obtained with two different centrifugation protocols , 2017, Cytokine.

[25]  W. Chan,et al.  Platelet-Rich Fibrin Facilitates Rabbit Meniscal Repair by Promoting Meniscocytes Proliferation, Migration, and Extracellular Matrix Synthesis , 2017, International journal of molecular sciences.

[26]  John P. Cole,et al.  Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems , 2017, International journal of molecular sciences.

[27]  S. Ghanaati,et al.  Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP , 2017, International journal of molecular sciences.

[28]  Kohya Uematsu,et al.  Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF) , 2016, International journal of implant dentistry.

[29]  J. Marchal,et al.  Intra-Articular Injections of Platelet-Rich Plasma versus Hyaluronic Acid in the Treatment of Osteoarthritic Knee Pain: A Randomized Clinical Trial in the Context of the Spanish National Health Care System , 2016, International journal of molecular sciences.

[30]  A. Balduíno,et al.  Platelet-Rich Plasma Obtained with Different Anticoagulants and Their Effect on Platelet Numbers and Mesenchymal Stromal Cells Behavior In Vitro , 2016, Stem cells international.

[31]  J. U. Carmona,et al.  Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel , 2015, BMC Veterinary Research.

[32]  N. Maffulli,et al.  Use of Platelet-Rich Plasma for Patellar Tendon and Medial Collateral Ligament Injuries: Best Current Clinical Practice , 2014, The Journal of Knee Surgery.

[33]  J. Pinto,et al.  Application of platelet-rich plasma in the treatment of chronic skin ulcer - Case report* , 2014, Anais brasileiros de dermatologia.

[34]  N. Maffulli,et al.  Platelet-rich plasma for managing pain and inflammation in osteoarthritis , 2013, Nature Reviews Rheumatology.

[35]  B. Cho,et al.  Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated Groups , 2013, Archives of plastic surgery.

[36]  M. Bachem,et al.  Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt , 2013, British journal of haematology.

[37]  R. Borojevic,et al.  Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors , 2013, Stem Cell Research & Therapy.

[38]  N. Shubhashini,et al.  Platelet rich fibrin: a new paradigm in periodontal regeneration , 2012, Cell and Tissue Banking.

[39]  A. Lubkowska,et al.  Growth factor content in PRP and their applicability in medicine. , 2012, Journal of biological regulators and homeostatic agents.

[40]  Y. Yatomi,et al.  Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. , 2012, Tissue engineering. Part C, Methods.

[41]  Sanjai Bhagat,et al.  Mathematical modeling indicates that regulatory inhibition of CD8+ T cell cytotoxicity can limit efficacy of IL-15 immunotherapy in cases of high pre-treatment SIV viral load , 2023, bioRxiv.

[42]  Jeong-Hee Yang,et al.  Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells , 2011, The Korean journal of hematology.

[43]  Kenneth S. Lee,et al.  Musculoskeletal applications of platelet-rich plasma: fad or future? , 2011, AJR. American journal of roentgenology.

[44]  Aditi Thakur,et al.  Platelet Concentrates: Past, Present and Future , 2011, Journal of maxillofacial and oral surgery.

[45]  A. Kantarcı,et al.  Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. , 2007, Journal of periodontology.

[46]  T. Kawase,et al.  Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. , 2003, Journal of periodontology.

[47]  A. G. Taylor,et al.  The role of alkaline phosphatase in cartilage mineralization. , 1992, Bone and mineral.